Free Trial

Cerillion (CER) Competitors

Cerillion logo
GBX 1,250 +5.00 (+0.40%)
As of 12:06 PM Eastern

CER vs. PRSM, KAPE, KNOS, TRST, and FBT

Should you buy Cerillion stock or one of its competitors? MarketBeat compares Cerillion with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Cerillion include Blue Prism Group (PRSM), Kape Technologies (KAPE), Kainos Group (KNOS), Trustpilot Group (TRST), and First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (FBT). These companies are all part of the "software - application" industry.

How does Cerillion compare to Blue Prism Group?

Cerillion (LON:CER) and Blue Prism Group (LON:PRSM) are both small-cap computer and technology companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, analyst recommendations, risk, media sentiment, institutional ownership, dividends, valuation and earnings.

18.3% of Cerillion shares are held by institutional investors. 21.2% of Cerillion shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Cerillion has a net margin of 32.24% compared to Blue Prism Group's net margin of 0.00%. Cerillion's return on equity of 22.77% beat Blue Prism Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Cerillion32.24% 22.77% 19.33%
Blue Prism Group N/A N/A N/A

In the previous week, Cerillion had 1 more articles in the media than Blue Prism Group. MarketBeat recorded 1 mentions for Cerillion and 0 mentions for Blue Prism Group. Cerillion's average media sentiment score of 0.00 equaled Blue Prism Group'saverage media sentiment score.

Company Overall Sentiment
Cerillion Neutral
Blue Prism Group Neutral

Cerillion currently has a consensus price target of GBX 1,972, indicating a potential upside of 57.76%. Given Cerillion's stronger consensus rating and higher probable upside, research analysts clearly believe Cerillion is more favorable than Blue Prism Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cerillion
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.80
Blue Prism Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Cerillion has higher earnings, but lower revenue than Blue Prism Group. Blue Prism Group is trading at a lower price-to-earnings ratio than Cerillion, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cerillion£42.46M8.70£14.14M£46.3027.00
Blue Prism Group£167.30M0.00N/A-£53.80N/A

Summary

Cerillion beats Blue Prism Group on 11 of the 12 factors compared between the two stocks.

How does Cerillion compare to Kape Technologies?

Kape Technologies (LON:KAPE) and Cerillion (LON:CER) are both small-cap computer and technology companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends, earnings and media sentiment.

Kape Technologies has a beta of 0.64, indicating that its share price is 36% less volatile than the broader market. Comparatively, Cerillion has a beta of 0.46, indicating that its share price is 54% less volatile than the broader market.

In the previous week, Cerillion had 1 more articles in the media than Kape Technologies. MarketBeat recorded 1 mentions for Cerillion and 0 mentions for Kape Technologies. Kape Technologies' average media sentiment score of 0.00 equaled Cerillion'saverage media sentiment score.

Company Overall Sentiment
Kape Technologies Neutral
Cerillion Neutral

11.4% of Kape Technologies shares are owned by institutional investors. Comparatively, 18.3% of Cerillion shares are owned by institutional investors. 81.1% of Kape Technologies shares are owned by company insiders. Comparatively, 21.2% of Cerillion shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Cerillion has a net margin of 32.24% compared to Kape Technologies' net margin of 11.37%. Cerillion's return on equity of 22.77% beat Kape Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Kape Technologies11.37% 6.97% 3.47%
Cerillion 32.24%22.77%19.33%

Cerillion has a consensus target price of GBX 1,972, indicating a potential upside of 57.76%. Given Cerillion's stronger consensus rating and higher probable upside, analysts plainly believe Cerillion is more favorable than Kape Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Kape Technologies
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Cerillion
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.80

Kape Technologies has higher revenue and earnings than Cerillion. Kape Technologies is trading at a lower price-to-earnings ratio than Cerillion, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kape Technologies£623.48M0.00£70.92M£0.15N/A
Cerillion£42.46M8.70£14.14M£46.3027.00

Summary

Cerillion beats Kape Technologies on 9 of the 14 factors compared between the two stocks.

How does Cerillion compare to Kainos Group?

Cerillion (LON:CER) and Kainos Group (LON:KNOS) are both small-cap computer and technology companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, risk, media sentiment, dividends, institutional ownership, analyst recommendations, earnings and valuation.

Kainos Group has higher revenue and earnings than Cerillion. Kainos Group is trading at a lower price-to-earnings ratio than Cerillion, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cerillion£42.46M8.70£14.14M£46.3027.00
Kainos Group£431.10M2.20£48.81M£35.1023.48

Cerillion has a net margin of 32.24% compared to Kainos Group's net margin of 9.86%. Kainos Group's return on equity of 41.45% beat Cerillion's return on equity.

Company Net Margins Return on Equity Return on Assets
Cerillion32.24% 22.77% 19.33%
Kainos Group 9.86%41.45%14.45%

Cerillion presently has a consensus price target of GBX 1,972, indicating a potential upside of 57.76%. Kainos Group has a consensus price target of GBX 1,173.40, indicating a potential upside of 42.35%. Given Cerillion's higher possible upside, equities analysts clearly believe Cerillion is more favorable than Kainos Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cerillion
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.80
Kainos Group
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
3.00

18.3% of Cerillion shares are owned by institutional investors. Comparatively, 38.2% of Kainos Group shares are owned by institutional investors. 21.2% of Cerillion shares are owned by company insiders. Comparatively, 20.3% of Kainos Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Cerillion pays an annual dividend of GBX 15.40 per share and has a dividend yield of 1.2%. Kainos Group pays an annual dividend of GBX 28.90 per share and has a dividend yield of 3.5%. Cerillion pays out 33.3% of its earnings in the form of a dividend. Kainos Group pays out 82.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Cerillion has a beta of 0.46, suggesting that its stock price is 54% less volatile than the broader market. Comparatively, Kainos Group has a beta of 0.815, suggesting that its stock price is 19% less volatile than the broader market.

In the previous week, Cerillion had 1 more articles in the media than Kainos Group. MarketBeat recorded 1 mentions for Cerillion and 0 mentions for Kainos Group. Kainos Group's average media sentiment score of 1.14 beat Cerillion's score of 0.00 indicating that Kainos Group is being referred to more favorably in the news media.

Company Overall Sentiment
Cerillion Neutral
Kainos Group Positive

Summary

Cerillion and Kainos Group tied by winning 9 of the 18 factors compared between the two stocks.

How does Cerillion compare to Trustpilot Group?

Trustpilot Group (LON:TRST) and Cerillion (LON:CER) are both small-cap computer and technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, risk, analyst recommendations, profitability, valuation, dividends, institutional ownership and earnings.

Cerillion has a net margin of 32.24% compared to Trustpilot Group's net margin of 2.97%. Trustpilot Group's return on equity of 64.11% beat Cerillion's return on equity.

Company Net Margins Return on Equity Return on Assets
Trustpilot Group2.97% 64.11% 1.45%
Cerillion 32.24%22.77%19.33%

Trustpilot Group presently has a consensus target price of GBX 351.25, indicating a potential upside of 45.35%. Cerillion has a consensus target price of GBX 1,972, indicating a potential upside of 57.76%. Given Cerillion's higher possible upside, analysts clearly believe Cerillion is more favorable than Trustpilot Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Trustpilot Group
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
3.00
Cerillion
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.80

Trustpilot Group has higher revenue and earnings than Cerillion. Cerillion is trading at a lower price-to-earnings ratio than Trustpilot Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Trustpilot Group£261.05M3.58£20.08M£1.80134.26
Cerillion£42.46M8.70£14.14M£46.3027.00

49.5% of Trustpilot Group shares are owned by institutional investors. Comparatively, 18.3% of Cerillion shares are owned by institutional investors. 13.5% of Trustpilot Group shares are owned by company insiders. Comparatively, 21.2% of Cerillion shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Trustpilot Group has a beta of 0.49, meaning that its stock price is 51% less volatile than the broader market. Comparatively, Cerillion has a beta of 0.46, meaning that its stock price is 54% less volatile than the broader market.

In the previous week, Trustpilot Group had 1 more articles in the media than Cerillion. MarketBeat recorded 2 mentions for Trustpilot Group and 1 mentions for Cerillion. Trustpilot Group's average media sentiment score of 0.87 beat Cerillion's score of 0.00 indicating that Trustpilot Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Trustpilot Group
0 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Cerillion
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Trustpilot Group beats Cerillion on 9 of the 15 factors compared between the two stocks.

How does Cerillion compare to First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation?

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT) and Cerillion (LON:CER) are both small-cap computer and technology companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, valuation, earnings, profitability and media sentiment.

Cerillion has a consensus target price of GBX 1,972, suggesting a potential upside of 57.76%. Given Cerillion's stronger consensus rating and higher probable upside, analysts clearly believe Cerillion is more favorable than First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Cerillion
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.80

Cerillion has a net margin of 32.24% compared to First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation's net margin of 0.00%. Cerillion's return on equity of 22.77% beat First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation's return on equity.

Company Net Margins Return on Equity Return on Assets
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD AccumulationN/A N/A N/A
Cerillion 32.24%22.77%19.33%

18.3% of Cerillion shares are owned by institutional investors. 21.2% of Cerillion shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Cerillion had 1 more articles in the media than First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation. MarketBeat recorded 1 mentions for Cerillion and 0 mentions for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation. First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation's average media sentiment score of 0.00 equaled Cerillion'saverage media sentiment score.

Cerillion has higher revenue and earnings than First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation. First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation is trading at a lower price-to-earnings ratio than Cerillion, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD AccumulationN/AN/AN/A-£1.10N/A
Cerillion£42.46M8.70£14.14M£46.3027.00

Summary

Cerillion beats First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation on 12 of the 12 factors compared between the two stocks.

Get Cerillion News Delivered to You Automatically

Sign up to receive the latest news and ratings for CER and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CER and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CER vs. The Competition

MetricCerillionSoftware IndustryComputer SectorLON Exchange
Market Cap£369.26M£4.95B£39.52B£2.81B
Dividend Yield1.29%4.01%3.16%6.16%
P/E Ratio27.0026.2280.88366.63
Price / Sales8.70246.83631.0786,437.92
Price / Cash17.4917.4149.0227.85
Price / Book7.614.329.947.90
Net Income£14.14M£22.26M£1.07B£5.89B
7 Day Performance1.21%-0.61%1.48%0.77%
1 Month Performance-6.02%11.80%6.43%1.59%
1 Year Performance-18.83%-9.05%159.85%73.17%

Cerillion Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CER
Cerillion
3.2066 of 5 stars
GBX 1,250
+0.4%
GBX 1,972
+57.8%
-21.6%£369.26M£42.46M27.00321
PRSM
Blue Prism Group
N/AN/AN/AN/A£1.24B£167.30MN/A1,025
KAPE
Kape Technologies
N/AN/AN/AN/A£1.22B£623.48M1,900.00850
KNOS
Kainos Group
4.1277 of 5 stars
GBX 878
+2.8%
GBX 1,173.40
+33.6%
+7.4%£1.02B£431.10M25.012,953
TRST
Trustpilot Group
3.232 of 5 stars
GBX 246.60
+2.8%
GBX 321
+30.2%
+6.9%£956.33M£261.05M137.00820

Related Companies and Tools


This page (LON:CER) was last updated on 6/16/2026 by MarketBeat.com Staff.
From Our Partners